Sciton, Inc. articles

BBL HEROic™ represents the latest advancement in BroadBand Light therapy for skin revitalization. It uses a multi-wavelength, IPL-based approach to address sun damage, pigmentation, redness, and signs of aging with precision and versatility. Unlike traditional lasers, it delivers numerous wavelengths that can be filtered and controlled for targeted results across multiple concerns in a single session.

Is BBL HEROic a Laser Treatment?

BBL HEROic uses BroadBand Light, an advan

When selecting aesthetic laser technology, practices face a core decision on platform architecture: modular systems that evolve with needs versus single-device platforms built for a single purpose. Each model affects clinical flexibility, capital planning, training workflows, and long-term competitiveness. This guide outlines the differences, advantages, and practical considerations to align technology with practice goals.

Understanding Platform Architecture

Key differences b

Launching a medspa is capital-intensive. Equipment decisions shape your treatment menu, clinical outcomes, patient experience, workflow efficiency, and long-term profitability. The goal is alignment: your devices should support your clinical philosophy, staffing model, and revenue strategy, not drive them. This guide outlines the essential equipment categories to evaluate before launching a medspa.

Defining Your Clinical Identity

Before comparing devices, clarify your target pat

Aesthetic laser adoption is a major capital decision for medical aesthetics practices. ROI is driven not by purchase price alone, but by sustained utilization, diversified treatments, and ongoing patient demand. A well-chosen platform expands capabilities, attracts new patients, and strengthens competitive position; a poorly chosen device can sit underutilized despite ongoing costs.

Key ROI drivers

• Treatment demand: High demand procedures stabilize patient

The requested Broadband Light Therapy resource could not be located. This page appears to be a 404 Not Found result, likely due to a mistyped address or an out-of-date link.

Related Sciton pages historically associated with educational content and laser/light-based therapies include:

• Myth Busters: The Truth About Laser Treatments in Summer
• You've Been Matched! Why BBL HEROic is the Perfect Fit for Your Practice
• Sciton’s 2024-25 Holiday Wishlist: Unwrap the S

Rapid adoption of GLP-1 medications for weight management has created new aesthetic considerations. An estimated 15.5 million adults have used a GLP-1 drug, and awareness is high: about 75% of Americans are familiar with GLP-1 therapies, and more than half view them as a strong option for obesity-related health management. Patients often achieve substantial weight loss but report unexpected changes in facial skin, prompting demand for aesthetic interventions to support their journey.

In

An estimated 15.5 million adults have used a GLP-1 weight-loss drug. A national Gallup poll finds about 75% of Americans are familiar with GLP-1 therapies, and more than half view these treatments as a strong option for obesity or weight-related health challenges. In practice, patients report rapid weight loss followed by skin changes often described as Ozempic face, including hollowing in the cheeks, under-eye depressions, laxity along the jawline and neck, and a decline in overall skin qual